Vinergy Capital Inc.

Vinergy Capital Inc.

VNNYF
Vinergy Capital Inc.US flagOther OTC
0.15
USD
-0.01
- -
20.57MMarket Cap
Vinergy Capital Inc.
VNNYF
(Other OTC)

Recent

price

0.15

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Vinergy Capital Inc. (CSE:VIN, OTCQB:VNNYF), formerly known as Vanguard Investments Corp. and incorporated on March 20, 2001 under the Alberta Business Corporations Act with headquarters at Suite 1600, 409 Granville Street, Vancouver, British Columbia, V6C 1T2, Canada, operates as an investment issuer focused on generating income and long-term capital appreciation through strategic investments in public and private companies, particularly in artificial intelligence technologies for healthcare and industrial applications; its portfolio includes equity stakes, debt securities, share purchase warrants, and subscription agreements in entities such as Netramark Holdings Inc., Treatment.com AI Inc., Verses AI Inc., Leef Brands Inc., Healthcare Accretion Group Inc. (49.33% ownership developing the MedMatrix AI platform for patient data optimization and revenue enhancement in U.S. healthcare providers), CWE European Holdings Inc. (hemp retail operations in Germany), Mentorhead Incorporated (doing business as Limmi, an FDA- and HIPAA-compliant AI platform for life sciences data analytics, drug discovery, and clinical efficiency tools), First Person Ltd. (functional mushrooms producer), and Algo8 Industrial AI Inc. (AI digital twins and automation solutions for process industries across India, UAE, UK, Netherlands, U.S., and Canada); the company targets control positions or active management involvement in investees with 1-5 year horizons, emphasizing quarterly valuation reviews using fair value methods including published market quotes for public shares and management judgments for private holdings. Recent developments include a name change to MedBright AI Investments Inc. effective November 7, 2023 with new CSE ticker MDAI (though filings reference ongoing VIN usage), a shift from prior cannabis and digital currency strategies to AI-centric investments, subscription for 4,500,000 shares in Algo8 for $900,000 in February 2025, realization of $1,117,682 gain on dispositions of public investments like Edge Total Intelligence, Verses AI Inc., and others during the year ended February 28, 2025 yielding total investment income of $2,072,932, impairment of loans and interests to Healthcare Accretion Group totaling approximately $1,043,895 plus additional $551,205, full impairment of Mentorhead and other level 3 private investments based on collectability uncertainties, termination of the Limmi intellectual property license and option agreement on August 15, 2024 with dissolution of related U.S. subsidiary Vinergy Licensing Corp., and partial sale of CWE stake amid Neural Therapeutics Inc.'s acquisition of 30.75% interest completed August 13, 2025; operations span Canada, U.S., Germany, and global AI/healthtech markets with fiscal year-end February 28.

Company News

APIChatGPT
  • Vinergy Capital Adds AI Expert to Investment Committee

  • Vinergy Capital Finalizes Investment in Privately-Backed Healthcare AI Platform Company Adding to its Healthcare AI Portfolio

  • Vinergy Capital Announces Closing of Non-Brokered Private Placement

  • Vinergy Provides Update on Healthcare AI Investments and Highlights from New Investor Presentation

  • Emerging Markets Report: Smart Minds, Smart Money

  • Vinergy to Make Investment in Healthcare AI Platform Company to Compliment Recent Investment in Healthcare Trained Model Company; Michael Dalsin to Head Investment Committee

  • Vinergy Completes Investment in Healthcare Accretion Group

  • Vinergy Capital Strengthens Board

  • Vinergy Capital Provides Corporate Update

  • Vinergy Appoints Todd Violette as CEO and Director to Drive Focus on Blockchain & Bitcoin Growth Opportunities

  • Vinergy Capital Appoints Mr. Scott Jackson, Founder of Essential Designs, as Chief Technology Officer

  • CORRECTION FROM SOURCE: Vinergy Closes Over-Subscribed Private Placement of Units

  • Vinergy Closes Over-Subscribed Private Placement of Units